Organizing Committee Members - Cardiology insights 2019
CEO of NAMED Program
Board of Directors for NAMI.org in Gwinnett
Dr. Keith Kantor(Biography)
Dr. Kantor has been an advocate of natural food and healthy living for 30 years. In 1994 he was appointed CEO of the largest all natural food company of its kind in the United States. He is currently CEO and Founder of NAMED Program, which helps people with substance abuse problems and the top twelve mental illnesses by using special menus and proper specific hydration. He is also on the Board of Directors for NAMI.org in Gwinnett. NAMI is the largest non profit in the United States dealing with Mental Illness including substance abuse. He has a PhD in Nutritional Science, a Doctorate in Naturopathic Medicine, and a Doctorate in Business Entrepreneurship. He also holds undergraduate degrees in Biology and Chemistry.
Dr. Keith Kantor(Research Area)
The premier doctor correlating nutritional food science with preventing and mitigating disease. He is also well known as the go to expert on helping substance abuse and mental illness naturally in the United States. Chaired the Natural Products Committee requested by Congress on product criteria and label specifications for all natural foods in the United States. Chaired the Blue Ribbon panel requested by Congress on lowering health care costs in the United States. He is on the Board of Directors and Vice President of the All Natural Food Council of North America, a 55 year old 501C3 that helps govern the all natural food industry. He is on the Communications Committee for the Natural Products Association, a 75 year old 501C3, that is the voice of the natural products industry and works very close with Congress. He is on the Board of Directors of NAMI, the Gwinnett Chapter. He has written three books which can be found on the websites below. Dr. Kantor has been on several hundred Radio shows, T. V. shows, Newspapers and Magazines, speaking on how to live a healthy lifestyle, how to help increase the successful withdrawal and lower the relapse rate of substance abuse, naturally through proper nutrition and proper alkaline hydration and how to naturally help the top twelve mental illnesses with specific natural nutrition and hydration. Dr. Kantor has been an officer in the U.S. Marine Corps since 1976, and just finished serving in the reserves in April 2016 after 40 years.
Director of the BioSpectroscopy Core Research Laboratory
California South University
Director of the BioSpectroscopy Core Research Laboratory at Faculty of Chemistry, California South University (CSU), Irvine, California, USA & President of American International Standards Institute (AISI) Irvine, California, USA
Alireza Heidari(Research Area)
His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Antiâ€“Cancer Nano Drugs, Nano Drugs Delivery, ATRâ€“FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. He has participated at more than four hundreds reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI), PubMed and Scopus Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, New Zealand, Scotland, Ireland, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Ukraine, Turkey, France, Swiss, Germany, Sweden, Norway, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Thailand, Taiwan, Hong Kong, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore.
Senior Scientist,Therapeutic Products Directorate
University of Ottawa
Harpal S. Buttar(Biography)
Dr. Buttar received his degree in Veterinary Medicine in 1961 from the Punjab University, Chandigarh, India. Before coming to Canada, he was Lecturer for about 2 years in the Department of Pharmacology (1961-1963) in his first alma mater, College of Veterinary Medicine, Hissar. In January 1964, he was awarded an overseas scholarship by the University of Alberta, Edmonton, Alberta, Canada, where he completed his MSc and PhD degrees in Pharmacology in 1966 and 1970, respectively. After a post-doctoral stint at the Wayne State University, Detroit, Michigan, USA, he joined as a Research Scientist level-1 (August 1971) at the Health Protection Branch, Ottawa, and was promoted to the rank of Research Scientist level-5 in April 1997 (highest scientific rank in the Federal Govt.). He conducted in vitro and in vivo studies in Pharmacology as well as in Reproductive & Developmental Toxicology. He was Head of the Reproductive Toxicology Section from 1977-1991. Dr. Buttar has worked as a Senior Scientist & Assessment Officer in the Therapeutic Products Directorate, Health Canada, and retired in January 2013. As an Assessment Officer, his roles and responsibilities included risk/benefit assessment of urology and anti-diabetic drugs, and hormonal contraceptive products, as well as regulatory decision making for the pre-marketing approval of drugs in the Reproduction & Urology Division, Bureau of Metabolism, Oncology and Reproductive Sciences. Additionally, he has a continuing interest in the R & D of drug discovery and in academic teaching. Since May 1994-Present, he has held cross-appointment of Adjunct Professorship in the Department of Pathology & Laboratory Medicine, Medical College, University of Ottawa, Canada. Previously, he also held the positions of Adjunct Professor in the Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, and at the Memorial University of Newfoundland, St. Johnâ€™s, Canada. He is also a scientific consultant to the Institute of Cardiovascular Sciences, Faculty of Medicine, University of Manitoba, Winnipeg, Canada. In June 2013, Dr. Buttar was appointed Visiting Professor in the Department of Pharmacology, School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece. He is currently serving as Visiting Professor in the Faculty of Pharmaceutical Sciences, Guru Nanak Dev University (GNDU), Amritsar, Punjab, India. At GNDU, Professor Buttar teaches a special course in Basic & Clinical Pharmacology, and helps the MPharm students in doing in vitro and in vivo studies and designing experimental protocols to evaluate the therapeutic potential of drugs and plant-derived products in animal models
Harpal S. Buttar(Research Area)
Pharmacology/toxicology and Prevention of cardiovascular diseases He is the author and co-author of three book chapters and 86 research and review papers published in peer-reviewed journals. Dr. Buttar has presented 165 papers at National and International Conferences, and has been guest speaker for 91 lectures, seminars, symposia, and workshops
Sree Gokulam Medical College and Research Foundation Trivandrum
Major. Dr. Biji Soman (Biography)
Major. Dr. Biji Soman graduated from Government Medical College, Trivandrum in 1996. Served in the Indian Army as a Short Service Commission (SSC) officer for 5 years. Joined Sree Utharadom Thirunal (SUT) Hospital in Trivandrum, a reputed tertiary care cardiac centre as Registrar in Cardiology and Cardiac Catheterisation Lab. Did Post Graduate Diploma in Clinical Cardiology from Kerala Institute of Medical Sciences (KIMS), Trivandrum, passed out with Distinction and First Rank in Kerala state. Obtained, Membership of Royal College of Physicians (MRCP UK) in 2013. Became substantive Consultant Cardiologist in 2014. Was elected as a collegiate member of Royal College of Physicians and Surgeons of Glasgow MRCPS (Glas) in 2014 and of Royal College of Physicians of Edinburgh MRCPE (Edin) in 2017. He is Fellow of European Society of Cardiology (FESC). Presently affiliated with Sree Gokulam Medical College and Research Foundation Trivandrum as Consultant Cardiologist
Major. Dr. Biji Soman (Research Area)
Won awards for best paper presentations in National Conferences. Faculty in International and National conferences in Clinical Cardiology. Has several academic publications to his credit in both National and International peer reviewed Scientific Journals. Areas of Interest: Cardiovascular diseases among women
Dr. Ellahham has served as Chief Quality Officer for SKMC since 2009. In his role, Dr. Ellahham has led the development of a quality and safety program that has been highly successful and visible and has been recognized internationally by a number of awards. As Chief Quality Officer and Global Healthcare Leader, Dr. Ellahham had a focus on ensuring that that implementation of these best practices leads to breakthrough improvements in clinical quality, patient safety, patient experience and risk management. Dr. Ellahham is a Board-certified internist, cardiologist, and vascular medicine senior consultant and continues to care for patients. He received his undergraduate degree in biology and his M.D. from the American University of Beirut, Beirut, Lebanon. Dr. Ellahham did his fellowship in Cardiology at the Medical College of Virginia (MCV) in the USA. After completing his fellowship, Dr. Ellahham worked in Washington DC in several clinical and leadership positions before moving to UAE in 2008. He led the First AHA GWTG Heart Failure Initiative outside the US and was the recipient of the AHA GWTG Award in Wash. DC. He is the champion of the AHA GWTG in the region. Dr. Ellahham continues to be an active clinician. He is board certified in internal medicine, vascular medicine, cardiology, and quality. He was recently recertified in 2017 by the American Board of Cardiology (ABIM). He demonstrated great skill and experience in the management of patients with heart failure, ischemic heart disease, and valvular heart disease and led a multi-disciplinary team in the care and delivery of advanced therapies to these patients. He has unique abilities to partner and engages local and regional referring providers. He is able to work in a highly matrixed environment, possess strong leadership and organizational skills and have an experience of working effectively in a large health system. He is a fellow of the American College of Cardiology and key member in Heart Failure and Transplant, Adult Congenital and Pediatric Cardiology, Cardio-oncology and Peripheral Vascular Disease Sections. He is currently Cleveland Clinic Caregiver and cardiology consultant in Cleveland Clinic Abu Dhabi, in Abu Dhabi, UAE
Samer Ellahham(Research Area)
Dr. Ellahham is an avid researcher; his research includes heart failure, acute coronary syndromes, second victim phenomenon, innovation, digital healthcare solutions, telemedicine, block chain, patient experience and engagement, lean six sigma, safety, bowtie risk management tool and KPI management. He is a recognized world-leader in these fields. He is the Eminent Editor of The Journal of Cardiology & Cardiovascular Therapy. In addition, he serves on the editorial board of American Journal of Medical Quality, Developments in Clinical & Medical Pathology (DCMP), the Joint Commission Journal on Quality and Patient Safety, Telehealth and Medicine Today (TMT), Blockchain journal (BHTY), Medical Science, Open Journal of Cardiatic Research, UPI Journal of Pharmaceutical, Medical and Health Sciences (UPI-JPMHS, Open Access Research in Anatomy, Gerontology & Geriatrics studies and Open Access Journal of Clinical Trials, Hypertension Today Journal and Focus on Hypertension Journal.